Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.68 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.68 |
| ▸ | FAAH | O00519 | 1/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9319036 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL142894 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL1512994 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL142895 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL5580237 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL23698920 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL7077314 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL4748378 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL6232663 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL3231126 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 894 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080323-A | Polyhydroxyalkanoate grafted ethylene-acrylic acid copolymer aqueous dispersion with self-emulsifying core-shell structure, preparation method and recyclable paper package thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122074085-A | Resin composition | 株式会社钟化 | 2026-05-22 | — | — | CN | claimed |
| WO-2026100273-A1 | METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE | ＮＴＴ株式会社 | 2026-05-15 | — | — | WO | claimed |
| WO-2026099917-A1 | METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, AND DEVICE FOR PRODUCING USEFUL SUBSTANCE | ＮＴＴ株式会社 | 2026-05-15 | — | — | WO | claimed |
| US-20260076887-A1 | PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS | PROCTER & GAMBLE (US) | 2026-03-19 | — | — | US | claimed |
| US-20260000596-A1 | SEMI-SYNTHETIC RHAMNOLIPIDS | PROCTER & GAMBLE (US) | 2026-01-01 | — | — | US | claimed |
| US-20260000078-A1 | ANTI-MICROBIAL SYSTEM | PROCTER & GAMBLE (US) | 2026-01-01 | — | — | US | claimed |
| US-20250268806-A1 | PERSONAL CARE COMPOSITION WITH A MULTIFUNCTIONAL INGREDIENT | THE PROCTER & GAMBLE COMPANY | 2025-08-28 | — | — | US | claimed |
| US-20250268805-A1 | PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS | THE PROCTER & GAMBLE COMPANY | 2025-08-28 | — | — | US | claimed |
| EP-4572612-A1 | USE OF A THERMOPLASTIC, BIOBASED AND BIODEGRADABLE MATERIAL HAVING BRITTLE FRACTURE MECHANICS AS THE SHELL FOR AN EGG OR EGG-REPLACEMENT PRODUCT, AND A VEGAN EGG-REPLACEMENT PRODUCT ENCASED BY SUCH A SHELL | Neggst Foods GmbH (DE) | 2025-06-25 | — | — | EP | claimed |
| WO-2003033418-A1 | ORGANIC WASTE TREATMENT | ADVANCED ENVIRONMENTAL TECHNOLOGIES PTY. LTD. (AU) | 2003-04-24 | — | — | WO | claimed |
| US-6472188-B1 | SYNTHESIZING AND ACCUMULATING POLYHYDROXYALKANOATES (PHA) IN A CELL OF A MICROORGANISM BY CULTURING THE MICROORGANISM HAVING POLYHYDROXYALKANOATE DEPOLYMERASE ACTIVITY, COLLECTING CULTURED POLYMER, SUBJECTING TO MICROBIAL ENZYME DEGRADATION | CHIROBIO INC. (KR) | 2002-10-29 | — | — | US | claimed |
| US-6228623-B1 | PLANT EXTRACTS CONTAINING BIODEGRADABLE POLYMERS | MONSANTO COMPANY | 2001-05-08 | — | — | US | claimed |
| EP-1044278-A1 | BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES | MONSANTO COMPANY (US) | 2000-10-18 | — | — | EP | claimed |
| EP-1036190-A1 | A METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACIDS BY AUTO-DEGRADATION OF POLYHYDROXYALKANOATES | ChiroBio Inc. (KR) | 2000-09-20 | — | — | EP | claimed |
| US-6091002-A | GENERATING A TRANSFORMED PLANT BY INSERTION NUCLEOTIDE SEQUENCE INTO CELLS, ISOLATING TRANSFORMED CELLS, REGENERATING THE TRANSFORMED CELLS TO FORM TRANSFORMED PLANTS, DETECTING CELLS THAT PRODUCE POLYMER | MONSANTO COMPANY (US) | 2000-07-18 | — | — | US | claimed |
| US-6008169-A | Refrigerator oil composition comprising saturated hydroxy fatty acids and derivatives thereof | IDEMITSU KOSAN CO., LTD. (JP) | 1999-12-28 | — | — | US | claimed |
| WO-1999035278-A1 | BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES | MONSANTO COMPANY (US) | 1999-07-15 | — | — | WO | claimed |
| WO-1999029889-A1 | A METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACIDS BY AUTO-DEGRADATION OF POLYHYDROXYALKANOATES | LG CHEMICAL LTD. (KR) | 1999-06-17 | — | — | WO | claimed |
| EP-0192296-A1 | Novel disaccharide and trisaccharide derivatives of the \"Lipid A\" type | AKZO N.V. (NL) | 1986-08-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250268805-A1 | PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS | SMURF1, CUTA, SMURF2 | GPR84 522/4885FFAR1 64/4885FFAR4 74/4885 |
| US-20260000596-A1 | SEMI-SYNTHETIC RHAMNOLIPIDS | LPAR3, LPAR1, LPAR2 | GPR84 442/4885FFAR1 55/4885FFAR4 112/4885 |
| US-20260000078-A1 | ANTI-MICROBIAL SYSTEM | MGLL, LIPA, LIPC | GPR84 3670/4885FFAR1 532/4885FFAR4 862/4885 |
| US-20260076887-A1 | PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS | CUTA, PHOSPHO1, MGLL | GPR84 1057/4885FFAR1 14/4885FFAR4 52/4885 |
| US-20250268806-A1 | PERSONAL CARE COMPOSITION WITH A MULTIFUNCTIONAL INGREDIENT | CUTA, LRAT, MGLL | GPR84 963/4885FFAR1 700/4885FFAR4 958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.